debt_leverage_profile
0.15x Total Debt / Equity (Conservative)
High
SEC-XBRL
interest_rate_sensitivity
20bps rate rise adds ~$30M annual interest expense given ~$13B gross debt; manageable at 3.5x net leverage but limits buyback capacity
Inferred
Agent_Inference
geopolitical_supply_exposure
Medium intensity; US-China trade tariffs on metals and components disrupt supply chains.
Medium
GICS-commodity-overlay-v1
supply_chain_dependency
Semiconductor components from Taiwan (orthopedic robotics) and medical-grade titanium/cobalt-chrome from Chinese processors
Inferred
Agent_Inference
international_expansion_readiness
EUR (~20% of revenue), CNY (~8%), JPY (~5%) exposure; yen and yuan devaluations created ~$400M headwind in 2022-2023 cycles
Inferred
Agent_Inference
geographic_footprint
Top markets Europe, China, Japan; EUR/USD, CNY/USD, JPY/USD volatility creates 3-5% annual revenue translation risk; hedging partially offsets
Inferred
Agent_Inference
commodity_exposure_profile
Medium intensity; commodities: Steel, Aluminum, Copper, Crude Oil (fuel), Rare Earth Elements, Plastics/Resins; geopolitical: US-China trade tariffs on metals and components disrupt supply chains.
Medium
GICS-commodity-overlay-v1
vendor_lock_dependency_score
No single vendor exceeds 30% of input costs; diversified across 2,000+ suppliers, but sole-source FDA-validated component suppliers create substitution friction
Inferred
Agent_Inference
business_model_type_primary
Minimal cloud disruption risk; core operations (ERP, manufacturing, surgical systems) can run on-premise; SaaS tools (Vocera, Sage) would need 90-day migration
Inferred
Agent_Inference
business_model_type_secondary
Medical device hardware and software hybrid; cloud dependency is moderate, not existential; hospital-facing software could face 30-60 day service degradation
Inferred
Agent_Inference
switching_cost_profile
Moderate-high API coupling via Vocera communication platform and Mako robotic surgical system integrations; hospital EHR integrations create sticky proprietary workflows
Inferred
Agent_Inference
howey_test_risk_index
Fails Howey Test entirely; revenue from physical medical device sales and services; no investment contract, no common enterprise, no profit expectation from others
Inferred
Agent_Inference
regulatory_burden_tier
Medium
Medium
GICS-regulatory-overlay-v1
data_sovereignty_risk
High GDPR exposure via patient data in Vocera/communications unit; CCPA applicable; operates data localization programs; breach risk carries €20M+ fine potential
Inferred
Agent_Inference
antitrust_exposure_flag
Elevated; Mako robotic system implant-tying practices under FTC scrutiny; orthopedic market consolidation post-Vocera/Wright acquisitions warrants ongoing monitoring
Inferred
Agent_Inference
regulatory_exposure_profile
Medium burden; regimes: FAA, DOT, OSHA, EPA, ITAR, FTC; Export controls and defense procurement rules create contract concentration risk.
Medium
GICS-regulatory-overlay-v1
revenue_model_type
~40% recurring (instrument lease, service contracts, Vocera SaaS, consumables pull-through); ~60% transactional (capital equipment, implant sales per-procedure)
Inferred
Agent_Inference
monetization_vector
Razor-and-blade model: capital equipment (Mako robot) placed at low margin to drive high-margin implant consumables and service contract recurring revenue
Inferred
Agent_Inference
pricing_architecture
Premium pricing on implants and robotics; GPO contract constraints limit list-price flex; 2-4% annual price increases on consumables; ASP erosion risk in China VBP
Inferred
Agent_Inference
pricing_power_rating
7/10; strong in robotics and neuro; moderate pressure from China volume-based procurement; US hospital consolidation compresses implant ASPs 1-2% annually
Inferred
Agent_Inference
target_gross_margin_bracket
64.0% Gross Margin (Premium (>60%))
High
SEC-XBRL
churn_vulnerability_index
Low free-rider risk; proprietary implant ecosystem locks hospitals in; Mako robot creates 7-10 year capital commitment; churn rate on service contracts below 5%
Inferred
Agent_Inference
headcount_cost_structure
Sublinear growth model; manufacturing scales with volume but sales force and R&D are relatively fixed; gross margin expansion demonstrates operating leverage above 10% revenue growth
Inferred
Agent_Inference
marginal_cost_of_growth
Marginal cost of incremental implant revenue is low (~35% COGS); robotics placement has high upfront cost but drives high-margin annuity; R&D fixed costs spread over scale
Inferred
Agent_Inference
franchise_compliance_risk
Not a franchise model; direct sales force globally; distributor network in emerging markets carries some compliance drift risk under FCPA; past DOJ settlements on record
Inferred
Agent_Inference
customer_acquisition_metric
At 10x scale, hospital penetration would require GPO renegotiation and surgeon training bottlenecks; CAC rises as greenfield hospitals depleted; robotics placement economics remain favorable
Inferred
Agent_Inference
network_effect_present
Weak direct network effects; strong data network effect as Mako captures surgical outcome data improving AI algorithms, creating defensible clinical evidence moat over time
Inferred
Agent_Inference
asset_efficiency_ratio
9.4% Return on Assets (Excellent)
High
SEC-XBRL
recession_resistance_tier
Tier 2 resilient; elective orthopedic procedures defer 6-18 months in recessions (2009: -8% revenue); trauma and neurovascular segments more recession-resistant; not fully defensive
Inferred
Agent_Inference
customer_segment_primary
Hospitals and health systems (IDNs) represent ~70% of revenue; top 10 IDN customers estimated at 15-20% of US revenue; concentration risk moderate
Inferred
Agent_Inference
customer_segment_secondary
Ambulatory surgery centers (ASCs) growing to ~20% of mix; surgeons as clinical champions are key influencers; government/VA hospitals ~5-8% of revenue globally
Inferred
Agent_Inference
characteristic_occupations
["11-0000 Management Occupations", "13-0000 Business and Financial Operations Occupations", "15-0000 Computer and Mathematical Occupations", "17-0000 Architecture and Engineering Occupations", "23-0000 Legal Occupations", "33-0000 Protective Service Occupations", "37-0000 Building and Grounds Cleaning and Maintenance Occupations", "41-0000 Sales and Related Occupations", "43-0000 Office and Administrative Support Occupations", "47-0000 Construction and Extraction Occupations", "49-0000 Installation, Maintenance, and Repair Occupations", "51-0000 Production Occupations", "53-0000 Transportation and Material Moving Occupations"]
High
SOC-2018/GICS-overlay
agent_automatable_labor_share
0.3 (HIL — ~30% of characteristic roles agent-automatable)
Medium
SOC-2018 + agentic-exposure-v1
capital_expenditure_profile
3.0% CapEx / Revenue (Low-CapEx Asset-Light)
High
SEC-XBRL
sec_cik
0000310764
High
SEC-EDGAR
ticker
SYK
High
SEC-EDGAR